Fundraising Fox
Adam Rosenthal
FounderFounder & CEO at Star Therapeutics · Co-founder and former CEO; Director at Electra Therapeutics
San Francisco Bay Area
Find your path to Adam
Sign up to see every warm intro you have to Adam
- Paths you didn't know you had: your email and LinkedIn already hold routes to Adam. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Adam Rosenthal is the CEO and Founder of Star Therapeutics, where he has led the invention and development of molecules including Enjaymo, an approved treatment for cold agglutinin disease, and several candidates in Phase 3 trials such as VGA039 for von Willebrand disease, ELA026 for secondary HLH, and Riliprubart for CIDP. His work is also associated with three acquisitions: Vega Therapeutics in a $2 billion deal at Phase 3, True North Therapeutics in an $825 million deal at Phase 1/2, and iPierian in a $725 million preclinical-stage deal.
Founder & CEO at Star Therapeutics
Intro paths
In turn, Adam can intro founders to Star Therapeutics's investors below.
Star Therapeutics's investors · 18
Co-founders at Star Therapeutics
Co-founder and former CEO; Director at Electra Therapeutics
Intro paths
In turn, Adam can intro founders to Electra Therapeutics's investors below.
Electra Therapeutics's investors · 7
Frequently asked questions
- Who is Adam Rosenthal?
- Adam Rosenthal is the CEO and Founder of Star Therapeutics, where he has led the invention and development of molecules including Enjaymo, an approved treatment for cold agglutinin disease, and several candidates in Phase 3 trials such as VGA039 for von Willebrand disease, ELA026 for secondary HLH, and Riliprubart for CIDP. His work is also associated with three acquisitions: Vega Therapeutics in a $2 billion deal at Phase 3, True North Therapeutics in an $825 million deal at Phase 1/2, and iPierian in a $725 million preclinical-stage deal.
- Where does Adam Rosenthal work?
- Adam Rosenthal is Co-founder and former CEO; Director of Electra Therapeutics and Founder & CEO at Star Therapeutics.
- What companies did Adam Rosenthal found?
- Adam Rosenthal founded Electra Therapeutics, Star Therapeutics.
Founder mafias
Massachusetts Institute of Technology mafia1,487
Also came through, then founded or led a company.
Electra Therapeutics mafia2
Also came through, then founded or led a company.
Star Therapeutics mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Star Therapeutics's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights